| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,666,307 | 3,802,404 | 5,426,499 | 4,215,187 | | Cost of Revenue | 2,384,992 | 2,765,513 | 4,041,511 | 2,132,312 | | | Gross Profit | 1,281,315 | 1,036,891 | 1,384,988 | 2,082,875 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 199,880 | 194,388 | (386,722) | 800,062 | | Non Recurring | 202,000 |
-
|
-
|
-
| | Others | 389,758 | 373,356 | 367,014 | 358,745 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 489,677 | 469,147 | 1,404,696 | 924,068 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,499 | (58,352) | 39,387 | (21,069) | | Earnings Before Interest And Taxes | 492,200 | 464,250 | 1,434,018 | 870,281 | | Interest Expense | 183,115 | 200,877 | 219,067 | 228,947 | | Income Before Tax | 309,085 | 263,373 | 1,214,951 | 641,334 | | Income Tax Expense | 167,169 | 77,395 | 434,515 | 224,952 | | Minority Interest |
-
| 48,584 | (16,194) | (32,390) | | | | Net Income From Continuing Ops | 141,916 | 185,978 | 780,436 | 416,382 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 141,916 | 185,978 | 780,436 | 416,382 | | Preferred Stock And Other Adjustments | (16,195) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $125,721 | $185,978 | $780,436 | $416,382 |
|
0.45% Nasdaq 
0.20%
Income Statement
